Autism Biotech
Belfast
About Autism Biotech
Autism Biotech develops biochemical test for the early reliable diagnosis of autism. Autism Biotech's product, ASDtect, a diagnostic test for early and reliable detection of autism spectrum disorder. Based on two fully owned and granted patents for peptide biomarkers for autism, ASDtect targets a huge and untapped market. The company is currently conducting trials and aims to make ASDtect available in the near future. Autism Biotech is headquartered in Belfast, Northern Ireland.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Non-Equity Assistance (Apr 2014)
- Website: autism-biotech.com
- Phone: +442890997007
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/autism-biotech-2137319 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.